Pioglitazone Hydrochloride

盐酸吡格列酮

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NamePioglitazone Hydrochloride
Drug Alias Name盐酸匹格列酮litazonumpiogPioglitazone hydrochloride thermogel - Strekin皮利酮盐酸盐吡格列酮 +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsRejection of renal transplantationAndrogen deficiencyCognitive Dysfunction +[73] 
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date1999/07/15
Country/TerritoryCzechiaBelgiumCanada +[32] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA IncThe University Of Texas Health Science Center At HoustonThe Ohio State University +[10] 
Inactive CompaniesUniversity of Texas Southwestern Medical CenterUT Health San AntonioGlaxosmithkline Plc +[43] 
Active IndicationsCocaine-Related DisordersAlcoholismObesity +[10] 
Inactive IndicationsRejection of renal transplantationAndrogen deficiencyCognitive Dysfunction +[63] 

Other Information

ATC CodeA10BG03
Related LinksWikipediaDrugBankKEGG